| Title: |
543 VIDAR-1: a phase 1/2a master protocol for open-label, multi-centre, single-arm, first-in-human clinical studies of autologous TCR-T therapy targeting mutant KRAS in metastatic or locally advanced PDAC |
| Authors: |
Salter, Hugh; Bashir, Zahid; Bethge, Wolfgang; Bitzer, Michel; Busse, Antonia; Carlsten, Mattias; Chen, Inna M; Desar, Ingrid ME; Herpen, Carla van; Kordes, Maximilian; Springfeld, Christoph; Wermke, Martin; Wilmink, Johanna; Jarvis, Reagan |
| Source: |
Regular and Young Investigator Award Abstracts ; page A619-A619 |
| Publisher Information: |
BMJ Publishing Group Ltd |
| Publication Year: |
2025 |
| Document Type: |
conference object |
| Language: |
unknown |
| DOI: |
10.1136/jitc-2025-sitc2025.0543 |
| DOI: |
10.1136/jitc-2025-SITC2025.0543 |
| Availability: |
https://doi.org/10.1136/jitc-2025-sitc2025.0543; https://syndication.highwire.org/content/doi/10.1136/jitc-2025-SITC2025.0543 |
| Rights: |
http://creativecommons.org/licenses/by-nc/4.0/ |
| Accession Number: |
edsbas.1052EB73 |
| Database: |
BASE |